T.-C. Yu and W.-C. Chou, “Challenges of Hepatitis B Virus Reactivation and CD19 Testing Following Tafasitamab Plus Lenalidomide for Relapsed Diffuse Large B-Cell Lymphoma”, J Med Cases, vol. 17, no. 5, pp. 231–237, Jan. 2026, doi: 10.14740/jmc5313.